跳至主要内容
临床试验/NL-OMON49236
NL-OMON49236已完成不适用

Exposure to orally administered antibiotics during the initial phase of infection in non-critically ill, febrile patients - EXPO-AB

Academisch Medisch Centrum0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Age *18 years
  • Acute febrile illness, defined as a temperature *38.3 and in need of IV
  • antibiotic therapy for an infection for which amoxicillin or ciprofloxacin are
  • registered treatments
  • Able to take oral medication, that is no abdominal pathology or history of
  • abdominal pathology that may alter absorption (i.e. vomiting, mucositis,
  • diarrhoea, malabsorption syndrome, former abdominal surgery affecting
  • absorption)
  • Able and willing to give informed consent

排除标准

  • Critically ill patients, admitted to the ICU, or infectious patients of the
  • general ward who became critically ill and got transferred to the ICU during
  • the research period.
  • Comorbidity affecting absorption: hepatic impairment, i.e. active hepatitis,
  • hepatic failure, liver cirrhosis or severe renal impairment (GFR <30),
  • Neutropenic patients (neutrophil count <1000/µl) and patients treated with
  • chemotherapy within 28 days prior to the study.
  • Contraindications to use ciprofloxacin or amoxicillin
  • o Ciprofloxacin: allergy to fluoroquinolones, concomitant administration of
  • o Amoxicillin: allergy to penicillins or proven allergy to another beta-lactam
  • agent (e.g. cephalosporin, carbapenem or monobactam).
  • Penicillin/fluoroquinolone treatment during the week prior to study enrolment
  • History of alcohol and drug abuse.

研究者

相似试验